secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORACLE CORP (ORCL)
CIK:        0001341439
Form:       8-K
Filed at:   2025-11-21T23:59:59+00:00
Accession:  0001193125-25-291441
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oracle adds former Quest CEO Stephen Rusckowski to board; all 13 directors re-elected at annual meeting
--------------------------------------------------------------------------------

- Stephen Rusckowski elected to Oracle's board effective Nov 18, 2025; board size increased to 14.
- Rusckowski was former CEO and President of Quest Diagnostics (2012–2022) and previously CEO of Philips Healthcare.
- 2025 annual meeting results: all 13 director nominees elected, advisory say-on-pay passed (1.92B for, 424M against), and Ernst & Young ratified as auditor (2.55B for).
- Rusckowski will receive pro-rata RSUs under Oracle's director stock plan and standard cash compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341439/000119312525291441/0001193125-25-291441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341439/000119312525291441/d43173d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-291441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer